Active Ingredient History
Busulfan is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Leukemia, Myeloid (approved 1954)
Acne Vulgaris (Phase 3)
Acquired Immunodeficiency Syndrome (Phase 1)
Adenocarcinoma, Clear Cell (Phase 1)
Adrenoleukodystrophy (Phase 2/Phase 3)
Aged (Phase 2/Phase 3)
Allogeneic Cells (Phase 2)
alpha-Mannosidosis (Phase 2)
Anemia (Phase 2)
Anemia, Aplastic (Phase 4)
Anemia, Diamond-Blackfan (Phase 2/Phase 3)
Anemia, Refractory (Phase 3)
Anemia, Sickle Cell (Phase 2/Phase 3)
Aspartylglucosaminuria (Phase 2)
Autoimmune Diseases (Phase 2)
beta-Thalassemia (Phase 4)
Biomarkers (Phase 1)
Bone Marrow Cells (Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Bone Marrow Transplantation (Phase 3)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Bronchiectasis (Phase 1)
Burkitt Lymphoma (Phase 2)
Busulfan (Phase 2/Phase 3)
Carcinoma, Renal Cell (Phase 1)
Chediak-Higashi Syndrome (Phase 2/Phase 3)
Chordoma (Phase 1)
Chromosome Aberrations (Phase 2)
Chronic Disease (Phase 2)
Common Variable Immunodeficiency (Phase 2)
Deficiency Diseases (Phase 2)
Disease-Free Survival (Phase 2)
Drug Therapy (Phase 2/Phase 3)
Endoscopy (Phase 2)
Epidermolysis Bullosa (Early Phase 1)
Fanconi Anemia (Phase 2)
Fetal Hemoglobin (Phase 2)
Fucosidosis (Phase 2/Phase 3)
Gangliosidosis, GM1 (Phase 2/Phase 3)
GATA2 Transcription Factor (Phase 2)
Gaucher Disease (Phase 2/Phase 3)
Genetic Diseases, Inborn (Phase 2)
Graft Survival (Phase 2)
Graft vs Host Disease (Phase 3)
Granuloma (Phase 1)
Granulomatous Disease, Chronic (Phase 2)
Hair (Phase 2/Phase 3)
Hematologic Diseases (Phase 2/Phase 3)
Hematologic Neoplasms (Phase 2)
Hematology (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 3)
Hemoglobinopathies (Phase 2)
Hemoglobin SC Disease (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2/Phase 3)
HIV (Phase 2)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 2)
Immune System Diseases (Phase 2/Phase 3)
Inflammatory Breast Neoplasms (Phase 2)
Intestinal Neoplasms (Phase 1)
Intraocular Lymphoma (Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 4)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 3)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 4)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 1/Phase 2)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 4)
Leukemia, Neutrophilic, Chronic (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 1/Phase 2)
Leukodystrophy, Globoid Cell (Phase 2/Phase 3)
Leukodystrophy, Metachromatic (Phase 2/Phase 3)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 1)
Lupus Erythematosus, Systemic (Phase 1)
Lymphohistiocytosis, Hemophagocytic (Phase 2/Phase 3)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2/Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Cutaneous (Phase 1/Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2/Phase 3)
Mannosidase Deficiency Diseases (Phase 2)
Mastocytosis (Phase 2)
Medulloblastoma (Phase 1/Phase 2)
Melanoma (Phase 1)
Metabolic Diseases (Phase 2)
Metabolism (Phase 1)
Metabolism, Inborn Errors (Phase 2)
Mucopolysaccharidoses (Phase 2/Phase 3)
Mucopolysaccharidosis I (Phase 2)
Mucopolysaccharidosis II (Phase 2)
Mucopolysaccharidosis VI (Phase 2)
Mucopolysaccharidosis VII (Phase 2)
Multiple Myeloma (Phase 4)
Mutation (Phase 2)
Myeloablative Agonists (Phase 2)
Myelodysplastic-Myeloproliferative Diseases (Phase 2/Phase 3)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Neuroblastoma (Phase 3)
Neurofibromatosis 1 (Phase 2)
Neuronal Ceroid-Lipofuscinoses (Phase 2/Phase 3)
Neutropenia (Phase 2/Phase 3)
Niemann-Pick Diseases (Phase 2/Phase 3)
Niemann-Pick Disease, Type B (Phase 2)
Niemann-Pick Disease, Type C (Phase 2)
Osteogenesis Imperfecta (Phase 1)
Osteopetrosis (Phase 2/Phase 3)
Ovarian Neoplasms (Phase 1)
Paraproteinemias (Phase 1/Phase 2)
Peripheral Blood Stem Cell Transplantation (Phase 1/Phase 2)
Peroxisomal Disorders (Phase 2)
Plasmacytoma (Phase 2)
Polycythemia Vera (Phase 2)
Precancerous Conditions (Phase 2)
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Primary Immunodeficiency Diseases (Phase 2)
Primary Myelofibrosis (Phase 2)
Recurrence (Phase 3)
Remission Induction (Phase 2)
Retinoblastoma (Phase 1)
Rhabdoid Tumor (Phase 1)
Rhabdomyosarcoma (Phase 1)
Sandhoff Disease (Phase 2/Phase 3)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 3)
Sarcoma, Myeloid (Phase 2)
Scleroderma, Systemic (Phase 1)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 2)
Shwachman-Diamond Syndrome (Phase 2/Phase 3)
Signs and Symptoms, Respiratory (Phase 2)
Sphingolipidoses (Phase 2)
Stem Cell Transplantation (Phase 3)
Tay-Sachs Disease (Phase 2/Phase 3)
Testicular Neoplasms (Phase 2)
Thalassemia (Phase 2/Phase 3)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 2)
Thymoma (Phase 2)
Transplantation (Phase 3)
Tumor Suppressor Protein p53 (Phase 2/Phase 3)
Vascular Grafting (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)
Whole-Body Irradiation (Phase 2/Phase 3)
Wilms Tumor (Phase 1)
Wiskott-Aldrich Syndrome (Phase 1/Phase 2)
Wolman Disease (Phase 2/Phase 3)
X-Linked Combined Immunodeficiency Diseases (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
